1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Cue Health Inc.

Cue Health Inc.

HLTHQ
Cue Health Inc.US flagOther OTC
0.00
USD
- -
- -
1,591.00Market Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
0.05
0.12
11.66
3.2
0.42
0.26
Basic EPS, GAAP
-0.16
-0.37
1.64
-1.31
-2.44
-1.8
Free Cash Flow per Basic Share
-0.12
0.13
-2.24
-1.1
-0.96
-0.58
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.49
-0.86
-0.45
-1.47
-3.87
- -
Tangible Book Value per Share
-0.45
-0.81
13.24
3.78
1.51
- -
Basic Weighted Avg Shares
128
128
53
148
153
155
Sales/Revenue/Turnover
7
15
616
474
64
40
Operating Margin (%)
-313.42
-293.2
30.89
-42.95
-429.4
-472.7
Depreciation Expense
4
6
33
49
56
44
Net Income, GAAP
-21
-47
86
-194
-373
-279
Effective Tax Rate (%)
- -
- -
27.49
- -
- -
- -
Profit Margin (%)
-310.99
-307.66
14.03
-40.93
-581.51
-702.93
Working Capital
11
28
503
300
67
- -
LT Debt
4
12
50
45
42
- -
Total Equity
-58
-101
707
576
250
- -
Return on Invested Capital (%)
- -
- -
39.83
- -
- -
- -
Return on Capital (%)
- -
- -
-339.24
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
7
6
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
43
42
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
155
155
- -
Market Capitalization
67
25
29

Working Capital

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
192
110
- -
Cash, Cash Equivalents & STI
111
81
- -
Accounts Receivable, Net
1
1
- -
Inventories
64
14
- -
Total Current Liabilities
58
43
- -
Payables & Accruals
48
34
- -
ST Debt
7
6
- -
Deferred Revenue
1
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-56.59%
Free Cash Flow
- -
- -
-9.33%
Net Income, GAAP
- -
- -
92.45%
Sales/Revenue/Turnover
- -
- -
-86.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
177
84
67
146
474
2023
24
8
15
17
64
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
0.02
-0.67
-0.45
-0.21
-1.31
2023
-0.62
-0.55
-0.31
- -
-2.44
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Clint Sever
Full Time Employees
726
Sector
Healthcare
Industry
Medical - Devices
Address
4980 Carroll Canyon Road San Diego CA United States of America 92121
IPO Date
Sep 24, 2021
CIK
0001628945
Website
cuehealth.com
Similar Companies
Telesis Bio, Inc. (TBIO)
Inspire Medical Systems, Inc. (INSP)
Adiuvo Investments S.A. (ADV.WA)
CellaVision AB (publ) (CEVI.ST)
Pulsenmore Ltd. (PULS.TA)
Nexeon MedSystems Inc. (NXNN)
Business
Cue Health Inc. previously operated as a healthcare technology firm, dedicated to delivering accessible and individualized diagnostic capabilities to both consumers and medical professionals. The company's core offering, the Cue Health platform, enabled access to lab-standard diagnostic tests in various settings, including at-home and point-of-care, complemented by on-demand virtual consultations and treatment pathways for diverse health and wellness requirements. Its comprehensive Cue Integrated Care platform was comprised of several key elements: a hardware component known as the Cue Health Monitoring System, which featured a portable, reusable Cue Reader, specialized single-use Cue Cartridges, and a Cue Wand for sample collection; a software solution called the Cue Data and Innovation Layer, offering cloud-based data management and analytical tools; Cue Virtual Care Delivery Applications, encompassing the Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations, designed for connectivity with electronic medical record systems, pharmacies, last-mile delivery services, clinician networks, and laboratories. Initially, a significant part of its business revolved around COVID-19 testing kits, with plans for broader diagnostic applications. Founded in 2010 and headquartered in San Diego, California, the company was initially known as Cue Inc. before adopting the name Cue Health Inc. in December 2017. However, facing significant challenges, including a heavy reliance on COVID-19 testing and an inability to pivot post-pandemic, Cue Health Inc., along with its affiliated entities, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware on May 28, 2024. This action followed the cessation of its operations and the layoff of its remaining workforce and executive team. Prior to the bankruptcy, the company had also received a warning from the Nasdaq regarding non-compliance, indicating an expected delisting of its common stock.